- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Mitogen-Activated Protein Kinase (MEK) Inhibitor
Total 77367 results
-
University of Heidelberg Medical CenterGerman Cancer Research Center; University Hospital Heidelberg; Array BioPharma; Coordinating Centre for Clinical Trials HeidelbergActive, not recruitingRelapsed or Refractory Multiple Myeloma | Patients With BRAFV600 E or BRAFV600K MutationGermany
-
University Hospital, CaenActive, not recruiting
-
PfizerTerminatedLow-grade Serous Ovarian Cancer | Low-grade Serous Fallopian Tube Cancer | Low-grade Serous Peritoneal CancerUnited States, Canada, Hungary, Spain, Belgium, France, United Kingdom, Australia, Czechia, Netherlands, Sweden, Italy, Denmark, Germany, Austria, Finland, Ireland, Norway, Poland
-
Peter Hosein, MDNovartis Pharmaceuticals; Incyte Corporation; University of Miami Sylvester Comprehensive...RecruitingPancreatic Ductal AdenocarcinomaUnited States
-
University Health Network, TorontoActive, not recruitingGallbladder Carcinoma | Biliary Tract CarcinomaCanada
-
University Health Network, TorontoWithdrawnGallbladder Carcinoma | Biliary Tract Carcinoma
-
Ohio State University Comprehensive Cancer CenterNovartis Pharmaceuticals; National Comprehensive Cancer NetworkCompletedStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Recurrent Rectal CancerUnited States
-
PfizerCompletedLocally Advanced or Metastatic NRAS Mutant MelanomaUnited States, Australia, Germany, Italy, Netherlands
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Adenocarcinoma | Endometrial Adenosquamous CarcinomaUnited States
-
West Cancer CenterAmgen; University of Tennessee Health Science CenterUnknownMelanoma | BRAF Gene MutationUnited States
-
GlaxoSmithKlineCompletedLung Cancer, Non-Small CellUnited States, Spain, Korea, Republic of, Netherlands, Greece, France, Italy, Hungary
-
Centre Leon BerardRecruiting
-
GlaxoSmithKlineCompletedNeoplasms | CancerUnited Kingdom, France
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.A., GenevaCompletedCancer | Solid TumorsFrance, Belgium, Australia, Netherlands
-
Technische Universität DresdenTerminatedBrain Metastases | Malignant Melanoma Stage IV | BRAF V600 MutationGermany
-
National Cancer Institute (NCI)TerminatedRecurrent Adult Diffuse Large Cell LymphomaUnited States
-
The Christie NHS Foundation TrustAstraZeneca; University of ManchesterCompleted
-
National Cancer Institute (NCI)CompletedStage IV Skin Melanoma | Recurrent Melanoma | Stage III Skin MelanomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedLiver Cancer | Hepatocellular CancerUnited States
-
SpringWorks Therapeutics, Inc.Active, not recruitingPlexiform Neurofibroma | Neurofibromatosis Type 1 (NF1)United States
-
GlaxoSmithKlineCompleted
-
TriHealth Inc.TriHealth Cancer Institute; TriHealth Surgical Institute; TriHealth Ultrasound... and other collaboratorsWithdrawnMelanoma (Skin) | Tumor Skin | BRAF Gene Mutation | Melanoma Stage IIIb-IVM1a | Metastasis SkinUnited States
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United Kingdom; Verastem, Inc.; Chugai PharmaceuticalRecruitingMultiple Myeloma | Ovarian Cancer | Lung Cancer | Solid TumoursUnited Kingdom
-
Array Biopharma, now a wholly owned subsidiary...TerminatedUveal MelanomaUnited States, France, Germany, Netherlands, Spain, United Kingdom
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineWithdrawnCancer | Metastatic Uveal Melanoma | GNA11 Mutation-positive Metastatic Melanoma | GNAQ Mutation-positive Metastatic Melanoma
-
GlaxoSmithKlineCompletedCancerUnited States, France
-
PfizerCompletedSolid Tumors Harboring a BRAF V600 MutationUnited States, France, Italy, Singapore, Australia, Spain, Switzerland, Canada, Belgium
-
Memorial Sloan Kettering Cancer CenterPlexxikon; Array BioPharmaCompletedGastrointestinal Stromal Tumor (GIST)United States
-
GlaxoSmithKlineCompletedMelanomaUnited States, Italy, United Kingdom, France, Sweden, Germany, Poland, Australia, Belgium, Austria, Canada, Czechia, Greece, Russian Federation, Ukraine, Norway, Switzerland, New Zealand, Argentina
-
Array Biopharma, now a wholly owned subsidiary...CompletedMetastatic Colorectal Cancer | Advanced Solid Tumors | Advanced or Metastatic Biliary CancerUnited States
-
PfizerTerminatedMetastatic Pancreatic Adenocarcinoma | BRAF Mutated MelanomaUnited States, Australia, Belgium, Canada, France, Italy, Spain, United Kingdom
-
GlaxoSmithKlineCompletedCancerUnited States, Korea, Republic of, Canada, France
-
GlaxoSmithKlineCompletedCancerUnited States, France, Germany, Belgium
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
National University Hospital, SingaporeSingapore General HospitalUnknown
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
Shanghai Chest HospitalCompleted
-
Immuneering CorporationRecruitingPancreas Adenocarcinoma | Non-small Cell Lung Cancer | Advanced Solid Tumor (Phase 1) | Malignant Melanoma (Cutaneous)United States
-
Novartis PharmaceuticalsCompletedAdvanced and Selected Solid TumorsBelgium, Spain, Canada, Switzerland, United States
-
Immuneering CorporationRecruitingPancreatic Adenocarcinoma | Advanced Solid Tumor | Non-small Cell Lung Cancer (NSCLC) | Malignant Melanoma (Cutaneous)United States
-
H. Lee Moffitt Cancer Center and Research InstituteRecruitingSkin Cancer | Melanoma (Skin) | Skin Carcinoma | Skin MelanomaUnited States
-
Novartis PharmaceuticalsCompletedAdenocarcinoma Lung Cancer; Squamous Cell Lung CarcinomaChina
-
National Cancer Institute (NCI)RecruitingHairy Cell LeukemiaUnited States
-
National Cancer Institute (NCI)RecruitingHairy Cell LeukemiaUnited States
-
Array Biopharma, now a wholly owned subsidiary...TerminatedHepatic ImpairmentUnited States
-
GlaxoSmithKlineCompleted